MedTrace Logo

Check of Optical Features and Accuracy of the Zeiss ZO Lens After Selection and Calculation With OKULIX

NCT00842959 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2011-06-16

No results posted yet for this study

Summary

It is planned to implant the intraocular lenses XL Stabi ZO and Invent ZO into the eyes of patients for whom a cataract operation is medically indicated. The lenses are marketed and CE certified. Their implantation is clinical routine.

In the trial the accuracy of prediction of target refraction and the difference between calculated and measured contrast vision will be examined for both lens types.

Conditions

  • Cataract

Interventions

DEVICE

Invent ZO

monofocal aspheric IOL for implantation into capsular bag

DEVICE

XL Stabi ZO

monofocal aspheric IOL for implantation into capsular bag

Sponsors & Collaborators

  • Carl Zeiss Meditec AG

    lead INDUSTRY

Principal Investigators

  • Jochen Wahl, MD · Universitäts-Augenklinik Mainz

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2011-01-31
Completion
2011-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00842959 on ClinicalTrials.gov